IGF2R and neoplasm: To determine if 2G11 mAb is capable of selectively targeting IGF2R-expressing OS tumors, this mAb and the isotype matching murine mAb MOPC-21 were radiolabeled with 111In and administered IP to 143B and OS-17 tumor-bearing mice.